FI982476A0 - Heteroatomeja sisältäviä trisyklisiä yhdisteitä - Google Patents

Heteroatomeja sisältäviä trisyklisiä yhdisteitä

Info

Publication number
FI982476A0
FI982476A0 FI982476A FI982476A FI982476A0 FI 982476 A0 FI982476 A0 FI 982476A0 FI 982476 A FI982476 A FI 982476A FI 982476 A FI982476 A FI 982476A FI 982476 A0 FI982476 A0 FI 982476A0
Authority
FI
Finland
Prior art keywords
compounds containing
containing heteroatoms
tricyclic compounds
various
immunosuppressant
Prior art date
Application number
FI982476A
Other languages
English (en)
Swedish (sv)
Inventor
Karl Baumann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929209815A external-priority patent/GB9209815D0/en
Priority claimed from GB939304927A external-priority patent/GB9304927D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of FI982476A0 publication Critical patent/FI982476A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
FI982476A 1992-05-07 1998-11-16 Heteroatomeja sisältäviä trisyklisiä yhdisteitä FI982476A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929209815A GB9209815D0 (en) 1992-05-07 1992-05-07 Organic compounds,processes for their production and their use
GB939304927A GB9304927D0 (en) 1993-03-10 1993-03-10 Organic compounds
FI932035A FI102612B1 (fi) 1992-05-07 1993-05-05 Menetelmä terapeuttisesti käyttökelpoisten trisyklo[18.6.1.0 ]heptakoseenien ja niiden johdannaisten valmistamiseksi

Publications (1)

Publication Number Publication Date
FI982476A0 true FI982476A0 (fi) 1998-11-16

Family

ID=26300836

Family Applications (2)

Application Number Title Priority Date Filing Date
FI932035A FI102612B1 (fi) 1992-05-07 1993-05-05 Menetelmä terapeuttisesti käyttökelpoisten trisyklo[18.6.1.0 ]heptakoseenien ja niiden johdannaisten valmistamiseksi
FI982476A FI982476A0 (fi) 1992-05-07 1998-11-16 Heteroatomeja sisältäviä trisyklisiä yhdisteitä

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI932035A FI102612B1 (fi) 1992-05-07 1993-05-05 Menetelmä terapeuttisesti käyttökelpoisten trisyklo[18.6.1.0 ]heptakoseenien ja niiden johdannaisten valmistamiseksi

Country Status (25)

Country Link
US (1) US5514685A (fi)
EP (1) EP0569337B1 (fi)
JP (1) JP2788392B2 (fi)
KR (1) KR100292311B1 (fi)
CN (1) CN1037773C (fi)
AT (1) ATE155787T1 (fi)
AU (1) AU668152B2 (fi)
CA (1) CA2095659C (fi)
CY (1) CY2126B1 (fi)
CZ (1) CZ291773B6 (fi)
DE (1) DE69312386T2 (fi)
DK (1) DK0569337T3 (fi)
ES (1) ES2105193T3 (fi)
FI (2) FI102612B1 (fi)
GR (1) GR3024754T3 (fi)
HU (2) HUT66531A (fi)
IL (1) IL105607A (fi)
MY (1) MY109602A (fi)
NO (1) NO305865B1 (fi)
NZ (1) NZ247553A (fi)
PH (1) PH30456A (fi)
RU (1) RU2126009C1 (fi)
SG (1) SG47011A1 (fi)
SK (1) SK282061B6 (fi)
TW (1) TW330936B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110603A (en) * 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
CZ289773B6 (cs) 1994-10-26 2002-04-17 Novartis Ag Farmaceutický prostředek pro místní aplikaci
MY129435A (en) 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates
PT1421939E (pt) 1998-03-26 2010-07-12 Astellas Pharma Inc Preparaã†o da libertaã†o sustentada de um composto de macrëlido como tracolimus
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
AU2003254566A1 (en) 2002-07-23 2004-02-09 Novartis Ag Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
KR100469917B1 (ko) * 2002-09-09 2005-02-02 (주)조은식품 구수한 호박씨가 첨가된 호박엿 및 그 제조방법
KR100745493B1 (ko) * 2005-12-16 2007-08-03 주식회사농심 조직감이 향상된 사출 스낵 및 그 제조 방법
JP5739517B2 (ja) * 2010-04-02 2015-06-24 ヤンセン・アールアンドデイ・アイルランド 大環状インテグラーゼ阻害剤
ES2898849T3 (es) 2014-10-28 2022-03-09 Koushi Yamaguchi Medicamento para mejorar el síndrome de hipertensión inducida por el embarazo
JP7465806B2 (ja) 2018-08-10 2024-04-11 晃史 山口 母体と胎児との関係における液性免疫関連疾患の治療薬
WO2020129348A1 (ja) 2018-12-18 2020-06-25 晃史 山口 不妊・不育症または妊娠状態を改善するための薬剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5254562A (en) * 1984-12-03 1993-10-19 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
CA1316916C (en) * 1988-10-12 1993-04-27 David Askin Hydroxide mediated fk-506 rearrangement product
EP0364031B1 (en) * 1988-10-12 1992-12-23 Merck & Co. Inc. Hydroxide mediated fk-506 rearrangement process
CA2032159A1 (en) * 1989-06-14 1990-12-15 Andrew J. F. Edmunds Heteroatoms-containing tricyclic compounds
EP0413532A3 (en) * 1989-08-18 1991-05-15 Fisons Plc Macrocyclic compounds
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
US5260301A (en) * 1990-03-01 1993-11-09 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical solution containing FK-506
GB2246350A (en) * 1990-07-23 1992-01-29 Fujisawa Pharmaceutical Co Tricyclo compounds
EP0480623A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity
WO1992013862A1 (en) * 1991-02-05 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Lactone compounds
EP0638082A1 (en) * 1991-09-05 1995-02-15 Abbott Laboratories Macrocyclic immunomodulators

Also Published As

Publication number Publication date
AU3839393A (en) 1993-11-11
DE69312386D1 (de) 1997-08-28
SG47011A1 (en) 1998-03-20
TW330936B (en) 1998-05-01
CA2095659A1 (en) 1993-11-08
NO931627D0 (no) 1993-05-05
EP0569337B1 (en) 1997-07-23
DK0569337T3 (da) 1998-01-19
NO305865B1 (no) 1999-08-09
FI932035A0 (fi) 1993-05-05
FI932035A (fi) 1993-11-08
CN1037773C (zh) 1998-03-18
PH30456A (en) 1997-05-28
JPH0641144A (ja) 1994-02-15
AU668152B2 (en) 1996-04-26
ATE155787T1 (de) 1997-08-15
US5514685A (en) 1996-05-07
GR3024754T3 (en) 1997-12-31
CN1083486A (zh) 1994-03-09
SK282061B6 (sk) 2001-10-08
HU211135A9 (en) 1995-10-30
MY109602A (en) 1997-03-31
ES2105193T3 (es) 1997-10-16
CA2095659C (en) 2005-08-09
IL105607A0 (en) 1993-09-22
KR100292311B1 (ko) 2001-09-17
CZ291773B6 (cs) 2003-05-14
EP0569337A1 (en) 1993-11-10
NO931627L (no) 1993-11-08
HUT66531A (en) 1994-12-28
CZ82993A3 (en) 1994-01-19
NZ247553A (en) 1995-07-26
FI102612B (fi) 1999-01-15
DE69312386T2 (de) 1998-01-29
FI102612B1 (fi) 1999-01-15
HU9301190D0 (en) 1993-07-28
RU2126009C1 (ru) 1999-02-10
SK43593A3 (en) 1995-07-11
JP2788392B2 (ja) 1998-08-20
KR940005631A (ko) 1994-03-22
CY2126B1 (en) 2002-06-21
IL105607A (en) 1998-01-04

Similar Documents

Publication Publication Date Title
ATE168992T1 (de) 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline
TW269678B (fi)
MX9304646A (es) Nuevas 7-(sustituido)-8-(sustituido)d-9-[(glicilo sustituido)amido]-6-desmetil-6-desoxitetraciclinasy metodo para su produccion.
DE69331774D1 (de) 7-Substituierte-8-substituierte-9-substituierte Amino-7-Demethyl-6-Deoxy-Tetracycline als antibiotische Mittel
DE69433784D1 (de) 9-(Substituiertes Glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxytetracycline
FI982476A0 (fi) Heteroatomeja sisältäviä trisyklisiä yhdisteitä
PT626385E (pt) Derivados do tetra-hidropirano
GB2294927B (en) New 2,2,6,6-tetramethyl-piperidine derivatives for use as stabilizing agents for organic materials against light,heat and oxidation
ATE182594T1 (de) Thiazolotriazol- und thiazolodiazolderivate mit fungizider aktivität
AU2704492A (en) Improvements in or relating to organic compounds
NO305556B1 (no) Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer
DE69313931D1 (de) Polycyclische 31668P- und 31668U-Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als antibiotische oder antitumorale Arzneistoffe
GB9522273D0 (en) New 2,2,6,6-tetramethyl-piperidine derivatives for use as stabilizing agents for organic materials against light,heat and oxidation